Lv1
98 积分 2023-03-16 加入
A pharmacokinetic and pharmacodynamic drug-drug interaction study of dorzagliatin and empagliflozin in patients with type 2 diabetes and obesity: an open-label phase I trial
3天前
已关闭
Feasibility of using OGTT 1-h PG as a diagnostic criterion for diabetes and pre-diabetes
3天前
求助中
Interleukin 23 inhibitors for psoriasis: not just another number
3天前
求助中
Interleukin 23 inhibitors for psoriasis: not just another number
3天前
已关闭
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
4天前
已完结
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
6天前
已关闭
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
6天前
已关闭
Dynamic Surveillance of the Cardiovascular Risk and Identification of Treatment Responders in Type 2 Diabetes Using A Machine Learning-Based Model
10天前
已完结
Real-world outcomes and tolerability of Janus kinase inhibitors in chronic spontaneous urticaria and chronic inducible urticaria: A single-center retrospective study
11天前
已完结
阿尔茨海默病高危因素管理专家共识（2026版）
12天前
已完结
皖公网安备34019202002308